Cargando…
Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts
Prognostic biomarkers serve a variety of purposes in cancer treatment and research, such as prediction of cancer progression, and treatment eligibility. Despite growing interest in multi-omic data integration for defining prognostic biomarkers, validated methods have been slow to emerge. Given that...
Autores principales: | Thompson, Jeffrey A., Christensen, Brock C., Marsit, Carmen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979962/ https://www.ncbi.nlm.nih.gov/pubmed/29581450 http://dx.doi.org/10.1038/s41598-018-23494-0 |
Ejemplares similares
-
Correlation between pathologic complete response, event-free survival/disease-free survival and overall survival in neoadjuvant and/or adjuvant HR+/HER2-breast cancer
por: Gogate, Anagha, et al.
Publicado: (2023) -
Radiomics of rectal cancer for predicting distant metastasis and overall survival
por: Li, Mou, et al.
Publicado: (2020) -
Nomogram for predicting overall survival in colorectal cancer with distant metastasis
por: Liu, Zheng, et al.
Publicado: (2021) -
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
por: Yamamoto, Takaya, et al.
Publicado: (2022) -
Association of radiation dose intensity with overall survival in patients with distant metastases
por: Kao, Johnny, et al.
Publicado: (2021)